High remission rate, short remission duration in patients with refractory anemia with excess blasts (RAEB) in transformation (RAEB-t) given acute myelogenous leukemia (AML)-type chemotherapy in combination with granulocyte-CSF (G-CSF)

E. H. Estey; H. M. Kantarjian; S. O'Brien; S. Kornblau; M. Andreeff; M. Beran; S. Pierce; M. Keating

High remission rate, short remission duration in patients with refractory anemia with excess blasts (RAEB) in transformation (RAEB-t) given acute myelogenous leukemia (AML)-type chemotherapy in combination with granulocyte-CSF (G-CSF)

E. H. Estey, H. M. Kantarjian, S. O'Brien, S. Kornblau, M. Andreeff, M. Beran, S. Pierce, M. Keating

Leukemia

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	21-28
Number of pages	8
Journal	Cytokines and Molecular Therapy
Volume	1
Issue number	1
State	Published - Mar 1995

ASJC Scopus subject areas

Immunology and Allergy
Pharmacology

Cite this

Estey, E. H., Kantarjian, H. M., O'Brien, S., Kornblau, S., Andreeff, M., Beran, M., Pierce, S., & Keating, M. (1995). High remission rate, short remission duration in patients with refractory anemia with excess blasts (RAEB) in transformation (RAEB-t) given acute myelogenous leukemia (AML)-type chemotherapy in combination with granulocyte-CSF (G-CSF). Cytokines and Molecular Therapy, 1(1), 21-28.

High remission rate, short remission duration in patients with refractory anemia with excess blasts (RAEB) in transformation (RAEB-t) given acute myelogenous leukemia (AML)-type chemotherapy in combination with granulocyte-CSF (G-CSF). / Estey, E. H.; Kantarjian, H. M.; O'Brien, S. et al.
In: Cytokines and Molecular Therapy, Vol. 1, No. 1, 03.1995, p. 21-28.

Research output: Contribution to journal › Article › peer-review

Estey, EH, Kantarjian, HM, O'Brien, S, Kornblau, S , Andreeff, M, Beran, M, Pierce, S & Keating, M 1995, 'High remission rate, short remission duration in patients with refractory anemia with excess blasts (RAEB) in transformation (RAEB-t) given acute myelogenous leukemia (AML)-type chemotherapy in combination with granulocyte-CSF (G-CSF)', Cytokines and Molecular Therapy, vol. 1, no. 1, pp. 21-28.

@article{5ff93064d44a41f69dccf8d4531cdb44,

title = "High remission rate, short remission duration in patients with refractory anemia with excess blasts (RAEB) in transformation (RAEB-t) given acute myelogenous leukemia (AML)-type chemotherapy in combination with granulocyte-CSF (G-CSF)",

author = "Estey, {E. H.} and Kantarjian, {H. M.} and S. O'Brien and S. Kornblau and M. Andreeff and M. Beran and S. Pierce and M. Keating",

year = "1995",

month = mar,

language = "English (US)",

volume = "1",

pages = "21--28",

journal = "Cytokines and Molecular Therapy",

issn = "1355-6568",

publisher = "Taylor and Francis Ltd.",

number = "1",

}

TY - JOUR

T1 - High remission rate, short remission duration in patients with refractory anemia with excess blasts (RAEB) in transformation (RAEB-t) given acute myelogenous leukemia (AML)-type chemotherapy in combination with granulocyte-CSF (G-CSF)

AU - Estey, E. H.

AU - Kantarjian, H. M.

AU - O'Brien, S.

AU - Kornblau, S.

AU - Andreeff, M.

AU - Beran, M.

AU - Pierce, S.

AU - Keating, M.

PY - 1995/3

Y1 - 1995/3

UR - http://www.scopus.com/inward/record.url?scp=0029257297&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029257297&partnerID=8YFLogxK

M3 - Article

C2 - 9384660

AN - SCOPUS:0029257297

SN - 1355-6568

VL - 1

SP - 21

EP - 28

JO - Cytokines and Molecular Therapy

JF - Cytokines and Molecular Therapy

IS - 1

ER -

High remission rate, short remission duration in patients with refractory anemia with excess blasts (RAEB) in transformation (RAEB-t) given acute myelogenous leukemia (AML)-type chemotherapy in combination with granulocyte-CSF (G-CSF)

ASJC Scopus subject areas

Other files and links

Cite this